查看購物車
  • Simplified Chinese
  • English
2021-2031年亞太地區栓塞器材市場報告：範圍、細分、動態與競爭分析
市場調查報告書
商品編碼
1871491

2021-2031年亞太地區栓塞器材市場報告：範圍、細分、動態與競爭分析

Asia Pacific Embolization Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 188 Pages | 訂單完成後即時交付

價格

預計亞太地區栓塞器械市場將顯著成長，到 2031 年將達到約 13.0234 億美元，高於 2024 年的 6.591 億美元，2025 年至 2031 年的年複合成長率(CAGR) 預計為 10.3%。

執行摘要和市場分析

市場分為多個區域，包括中國、日本、印度、韓國、澳洲以及亞太其他地區。推動市場成長的關鍵因素是癌症和其他疾病發生率的上升，這增加了對栓塞等介入治療的需求。此外，技術的進步顯著提高了栓塞裝置的療效和安全性，包括藥物洗脫微球、微導管和新型彈簧圈設計等創新技術。這些改進不僅改善了臨床療效，還縮短了手術時間，減少了術後併發症，使這些手術對醫護人員和患者更具吸引力。

微創手術技術的普及是推動市場成長的另一個關鍵因素。與傳統手術相比，微創手術具有許多優勢，包括住院時間更短、恢復更快、併發症風險更低。隨著醫護人員和病患對這些優勢的認知不斷提高，預計栓塞手術的需求將會增加。

市場區隔分析

亞太地區栓塞器械市場可按類型、應用和最終用戶進行細分。

  • 依類型分類：市場產品包括栓塞線圈、栓塞塞、栓塞珠、栓塞膠等。 2024年，栓塞線圈佔據最大的市場佔有率，並進一步細分為中心栓塞和周邊栓塞。
  • 按應用領域分類：市場分為神經病學、周邊血管疾病、腫瘤學、泌尿學和其他領域，其中神經病學在 2024 年將成為領先領域。
  • 按最終用戶分類：最終用戶主要是醫院、門診中心等，預計到 2024 年，醫院將佔據市場佔有率的主導地位。

市場展望

栓塞術是一種微創技術，它透過導管輸送栓塞劑，阻斷特定區域（例如腫瘤或異常血管）的血流。此方法廣泛用於治療動靜脈畸形（AVM）、動脈瘤和某些癌症。由於其相較於傳統手術方法具有許多優勢，例如住院時間更短、併發症發生率更低、恢復更快，因此栓塞術越來越受到青睞。

例如，子宮動脈栓塞術是治療子宮肌瘤的有效替代方法，其成功率超過90%，同時仍保留子宮功能，這對育齡婦女尤其重要。此外，老年合併多種疾病的患者通常更傾向於微創治療。經動脈化療栓塞術（TACE）已成為肝細胞癌（HCC）的第一線標準治療方法，HCC是老年人常見的肝癌。 TACE中使用微球和載藥微球不僅可以阻斷血液供應，還能局部遞送化療藥物，從而提高治療效果並最大限度地減少全身副作用。據美國國家癌症研究所稱，TACE可將中期HCC患者的中位存活期延長至20個月，為手術切除提供了更安全的替代方案。

生物可吸收栓塞材料的出現是市場上的另一個重大進展，它能提供暫時性的血管阻塞，並被人體逐漸吸收，從而減少長期併發症，並為未來的治療提供更多選擇。隨著醫療系統越來越傾向於微創和經濟有效的介入治療，患者和臨床醫生都優先考慮那些能夠最大限度減少創傷、縮短恢復時間和降低併發症的治療方案。因此，栓塞術正逐漸成為傳統手術的更佳替代方案，為患者提供標靶治療、緩解症狀並改善生活品質。

國家概況

亞太地區栓塞器械市場涵蓋中國、日本、印度、澳洲、韓國等主要國家，預計2024年，中國將佔最大的市場佔有率。中國面臨嚴重的周邊動脈疾病（PAD）負擔，據報道，2000年至2020年間，PAD病例增加了40%。中國是亞太地區第二型糖尿病患者人數最多的國家，而糖尿病是PAD的主要危險因子。在中國，糖尿病患者的PAD盛行率在6%至10%之間。

技術進步對市場成長至關重要，例如微創醫療等公司正引領著針對本地需求的栓塞器材的研發。收購和產品創新等策略措施在市場參與者中十分普遍。例如，格蘭德藥業收購了神明醫療科技，以增強其腫瘤介入產品線；而Zylox-Tonbridge的栓塞系統則於2024年初獲得批准。

公司簡介

栓塞器械市場的主要參與者包括美敦力、庫克醫療、史賽克、波士頓科學、泰爾茂、強生、雅培等。這些公司正致力於擴張、產品創新以及併購，以增強市場佔有率並為消費者提供創新解決方案。

目錄

第1章：引言

第2章：執行概要

  • 關鍵見解

第3章：研究方法

  • 二手研究
  • 初步研究
    • 假設的提出：
    • 宏觀經濟因素分析：
    • 發展基數：
    • 數據三角測量：
    • 國家層面資料：
  • 假設和局限性

第4章：亞太地區栓塞器材市場－主要市場動態

  • 亞太地區栓塞器材市場－主要市場動態
  • 市場促進因素
    • 臨床疾病盛行率上升
    • 對微創技術的需求日益成長
  • 市場限制
    • 栓塞術期間或之後出現的併發症
  • 市場機遇
    • 新產品開發及市場推廣核准
  • 未來趨勢
    • 透過臨床創新變革栓塞治療
  • 駕駛員和安全帶的影響：

第5章：栓塞器械市場－亞太地區分析

  • 2021-2031年亞太地區栓塞器材市場收入
  • 亞太地區栓塞器材市場預測分析

第6章：亞太地區栓塞器材市場分析－依產品類型分類

  • 栓塞線圈
  • 插頭
  • 珠
  • 膠水
  • 其他

第7章：亞太地區栓塞器材市場分析－依應用領域分類

  • 神經病學
  • 周邊血管疾病
  • 腫瘤學
  • 泌尿科
  • 其他

第8章：亞太地區栓塞器材市場分析－依最終使用者分類

  • 醫院
  • 門診中心
  • 其他

第9章：亞太地區栓塞器材市場—國別分析

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太其他地區

第10章：競爭格局

  • 關鍵參與者熱力圖分析
  • 公司定位與集中度

第11章：行業概況

  • 概述
  • 擴張
  • 新產品開發與核准
  • 併購
  • 夥伴關係與合作

第12章：公司簡介

  • Medtronic Plc
  • Cook Medical Holdings LLC
  • Stryker Corp
  • Boston Scientific Corp
  • Terumo Corp
  • Johnson & Johnson
  • Abbott Laboratories
  • NeuroSafe Medical Co. Ltd
  • Wallaby Medical
  • Sirtex Medical Ltd
  • GEM srl
  • Penumbra Inc.
  • Balt
  • Lepu Medical Technology Beijing Co Ltd
  • INVAMED
  • Meril Life Sciences Pvt Ltd
  • Merit Medical Systems Inc
  • Lifetech Scientific Corp

第13章：附錄

Product Code: BMIRE00032148

The Asia Pacific embolization devices market is projected to grow significantly, reaching approximately US$ 1,302.34 million by 2031, up from US$ 659.10 million in 2024, with an estimated compound annual growth rate (CAGR) of 10.3% from 2025 to 2031.

Executive Summary and Market Analysis

The market is divided into several regions, including China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. A key driver of this market growth is the rising incidence of cancer and other medical conditions, which increases the demand for interventional procedures like embolization. Additionally, advancements in technology have significantly improved the efficacy and safety of embolization devices, including innovations such as drug-eluting beads, microcatheters, and new coil designs. These improvements not only enhance clinical outcomes but also minimize procedure times and reduce post-operative complications, making these procedures more appealing to both healthcare providers and patients.

The trend towards minimally invasive surgical techniques is another crucial factor contributing to market growth. Such procedures offer numerous advantages, including shorter hospital stays, faster recovery, and a lower risk of complications compared to traditional surgeries. As awareness of these benefits grows among healthcare providers and patients, the demand for embolization procedures is expected to increase.

Market Segmentation Analysis

The Asia Pacific embolization devices market can be segmented by type, application, and end user.

  • By Type: The market includes embolization coils, plugs, beads, glues, and others. In 2024, embolization coils held the largest market share, further divided into central and peripheral applications.
  • By Application: The market is categorized into neurology, peripheral vascular disease, oncology, urology, and others, with neurology being the leading segment in 2024.
  • By End User: The end users are primarily hospitals, ambulatory centers, and others, with hospitals dominating the market share in 2024.

Market Outlook

Embolization is a minimally invasive technique that blocks blood flow to specific areas, such as tumors or abnormal blood vessels, using embolic agents delivered via catheters. This method is widely used for treating arteriovenous malformations (AVMs), aneurysms, and certain cancers. The preference for these techniques is increasing due to their advantages over traditional surgical methods, including reduced hospital stays, lower complication rates, and quicker recovery times.

For instance, uterine artery embolization is an effective alternative to hysterectomy for treating uterine fibroids, achieving success rates exceeding 90% while preserving uterine function, which is particularly important for women of reproductive age. Furthermore, older patients with comorbidities often prefer minimally invasive options. Transarterial chemoembolization (TACE) has become a standard first-line treatment for hepatocellular carcinoma (HCC), a prevalent liver cancer among older adults. The use of microspheres and drug-eluting beads in TACE not only blocks blood supply but also delivers localized chemotherapy, enhancing treatment efficacy and minimizing systemic side effects. According to the National Cancer Institute, TACE can extend median survival for intermediate-stage HCC patients to 20 months, providing a safer alternative to surgical resection.

The emergence of bioresorbable embolic materials is another significant development in the market, offering temporary occlusion that the body gradually absorbs, thus reducing long-term complications and allowing for future treatment options. As healthcare systems increasingly favor minimally invasive and cost-effective interventions, both patients and clinicians are prioritizing treatment options that minimize trauma, recovery time, and complications. Consequently, embolization is becoming a preferred alternative to traditional surgeries, providing targeted treatment, symptom relief, and improved quality of life for patients.

Country Insights

The Asia Pacific embolization devices market includes key countries such as China, Japan, India, Australia, South Korea, and others, with China holding the largest market share in 2024. China faces a significant burden of peripheral artery disease (PAD), with a reported 40% increase in cases from 2000 to 2020. The country has the highest number of type 2 diabetes patients in the region, which is a major risk factor for PAD. The prevalence of PAD among diabetic patients in China ranges from 6% to 10%.

Technological advancements are crucial for market growth, with companies like MicroPort leading the development of embolization devices tailored to local needs. Strategic activities, such as acquisitions and product innovations, are common among market players. For example, Grand Pharmaceutical acquired Shenming Medical Technology to enhance its tumor intervention product pipeline, while Zylox-Tonbridge received approval for its embolization system in early 2024.

Company Profiles

Key players in the embolization devices market include Medtronic, Cook Medical, Stryker, Boston Scientific, Terumo, Johnson & Johnson, Abbott Laboratories, and others. These companies are focusing on expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Asia Pacific Embolization Devices Market - Key Market Dynamics

  • 4.1 Asia Pacific Embolization Devices Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Clinical Conditions
    • 4.2.2 Burgeoning Demand for Minimally Invasive Techniques
  • 4.3 Market Restraints
    • 4.3.1 Complications Arising During or After Embolization
  • 4.4 Market Opportunities
    • 4.4.1 New Product Developments and Marketing Approvals
  • 4.5 Future Trends
    • 4.5.1 Transforming Embolization Through Clinical Innovation
  • 4.6 Impact of Drivers and Restraints:

5. Embolization Devices Market - Asia Pacific Analysis

  • 5.1 Asia Pacific Embolization Devices Market Revenue (US$ Million), 2021-2031
  • 5.2 Asia Pacific Embolization Devices Market Forecast Analysis

6. Asia Pacific Embolization Devices Market Analysis - by Product Type

  • 6.1 Embolization Coils
    • 6.1.1 Overview
    • 6.1.2 Embolization Coils: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Plugs
    • 6.2.1 Overview
    • 6.2.2 Plugs: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Beads
    • 6.3.1 Overview
    • 6.3.2 Beads: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Glues
    • 6.4.1 Overview
    • 6.4.2 Glues: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Others
    • 6.5.1 Overview
    • 6.5.2 Others: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Asia Pacific Embolization Devices Market Analysis - by Application

  • 7.1 Neurology
    • 7.1.1 Overview
    • 7.1.2 Neurology: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Peripheral Vascular Disease
    • 7.2.1 Overview
    • 7.2.2 Peripheral Vascular Disease: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Oncology
    • 7.3.1 Overview
    • 7.3.2 Oncology: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Urology
    • 7.4.1 Overview
    • 7.4.2 Urology: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Embolization Devices Market Analysis - by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Hospitals: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Ambulatory Centers
    • 8.2.1 Overview
    • 8.2.2 Ambulatory Centers: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Embolization Devices Market - Country Analysis

  • 9.1 Asia Pacific
    • 9.1.1 Asia Pacific Embolization Devices Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 Asia Pacific Embolization Devices Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.2 China: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.2.1 China: Asia Pacific Embolization Devices Market Share - by Product Type
        • 9.1.1.2.2 China: Asia Pacific Embolization Devices Market Share - by Embolization Coils
        • 9.1.1.2.3 China: Asia Pacific Embolization Devices Market Share - by Application
        • 9.1.1.2.4 China: Asia Pacific Embolization Devices Market Share - by End User
      • 9.1.1.3 Japan: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.3.1 Japan: Asia Pacific Embolization Devices Market Share - by Product Type
        • 9.1.1.3.2 Japan: Asia Pacific Embolization Devices Market Share - by Embolization Coils
        • 9.1.1.3.3 Japan: Asia Pacific Embolization Devices Market Share - by Application
        • 9.1.1.3.4 Japan: Asia Pacific Embolization Devices Market Share - by End User
      • 9.1.1.4 India: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.4.1 India: Asia Pacific Embolization Devices Market Share - by Product Type
        • 9.1.1.4.2 India: Asia Pacific Embolization Devices Market Share - by Embolization Coils
        • 9.1.1.4.3 India: Asia Pacific Embolization Devices Market Share - by Application
        • 9.1.1.4.4 India: Asia Pacific Embolization Devices Market Share - by End User
      • 9.1.1.5 Australia: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.5.1 Australia: Asia Pacific Embolization Devices Market Share - by Product Type
        • 9.1.1.5.2 Australia: Asia Pacific Embolization Devices Market Share - by Embolization Coils
        • 9.1.1.5.3 Australia: Asia Pacific Embolization Devices Market Share - by Application
        • 9.1.1.5.4 Australia: Asia Pacific Embolization Devices Market Share - by End User
      • 9.1.1.6 South Korea: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.6.1 South Korea: Asia Pacific Embolization Devices Market Share - by Product Type
        • 9.1.1.6.2 South Korea: Asia Pacific Embolization Devices Market Share - by Embolization Coils
        • 9.1.1.6.3 South Korea: Asia Pacific Embolization Devices Market Share - by Application
        • 9.1.1.6.4 South Korea: Asia Pacific Embolization Devices Market Share - by End User
      • 9.1.1.7 Rest of APAC: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.7.1 Rest of APAC: Asia Pacific Embolization Devices Market Share - by Product Type
        • 9.1.1.7.2 Rest of APAC: Asia Pacific Embolization Devices Market Share - by Embolization Coils
        • 9.1.1.7.3 Rest of APAC: Asia Pacific Embolization Devices Market Share - by Application
        • 9.1.1.7.4 Rest of APAC: Asia Pacific Embolization Devices Market Share - by End User

10. Competitive Landscape

  • 10.1 Heat Map Analysis by Key Players
  • 10.2 Company Positioning and Concentration

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Expansion
  • 11.3 New Product Development and Approval
  • 11.4 Merger and Acquisition
  • 11.5 Partnerships and Collaboration

12. Company Profiles

  • 12.1 Medtronic Plc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Cook Medical Holdings LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Stryker Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Boston Scientific Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Terumo Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Johnson & Johnson
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Abbott Laboratories
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 NeuroSafe Medical Co. Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Wallaby Medical
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Sirtex Medical Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 GEM srl
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Penumbra Inc.
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Balt
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 Lepu Medical Technology Beijing Co Ltd
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 INVAMED
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 Financial Overview
    • 12.15.5 SWOT Analysis
    • 12.15.6 Key Developments
  • 12.16 Meril Life Sciences Pvt Ltd
    • 12.16.1 Key Facts
    • 12.16.2 Business Description
    • 12.16.3 Products and Services
    • 12.16.4 Financial Overview
    • 12.16.5 SWOT Analysis
    • 12.16.6 Key Developments
  • 12.17 Merit Medical Systems Inc
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 Financial Overview
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments
  • 12.18 Lifetech Scientific Corp
    • 12.18.1 Key Facts
    • 12.18.2 Business Description
    • 12.18.3 Products and Services
    • 12.18.4 Financial Overview
    • 12.18.5 SWOT Analysis
    • 12.18.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Embolization Devices Market Segmentation
  • Table 2. Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product Type
  • Table 4. Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 6. Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. China: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 8. China: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 9. China: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 10. China: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 11. Japan: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 12. Japan: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 13. Japan: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 14. Japan: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 15. India: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 16. India: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 17. India: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 18. India: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 19. Australia: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 20. Australia: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 21. Australia: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 22. Australia: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 23. South Korea: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 24. South Korea: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 25. South Korea: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 26. South Korea: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 27. Rest of APAC: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 28. Rest of APAC: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 29. Rest of APAC: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 30. Rest of APAC: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 31. Glossary of Terms, Embolization Devices Market

List Of Figures

  • Figure 1. Asia Pacific Embolization Devices Market Segmentation - Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Asia Pacific Embolization Devices Market Revenue (US$ Million), 2021-2031
  • Figure 4. Asia Pacific Embolization Devices Market Share (%) - by Product Type (2024 and 2031)
  • Figure 5. Embolization Coils: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 6. Plugs: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Beads: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Glues: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Others: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Asia Pacific Embolization Devices Market Share (%) - by Application (2024 and 2031)
  • Figure 11. Neurology: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Peripheral Vascular Disease: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Oncology: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Urology: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Others: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Asia Pacific Embolization Devices Market Share (%) - by End User (2024 and 2031)
  • Figure 17. Hospitals: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Ambulatory Centers: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Others: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Asia Pacific Embolization Devices Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 21. China: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Japan: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. India: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Australia: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. South Korea: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Rest of APAC: Asia Pacific Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. Heat Map Analysis by Key Players
  • Figure 28. Company Positioning and Concentration